课题基金 / 基金详情

Analysis of multiplicity and polymorphism of drug transporters expressed in the liver.

Analysis of multiplicity and polymorphism of drug transporters expressed in the liver.
肝脏中表达的药物转运蛋白的多样性和多态性分析。
批准号:
09470501
负责人:
SUGIYAMA Yuichi
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SUGIYAMA Yuichi的其他基金

相似基金

相关文献

中文摘要
翻译
肝脏,连同肾脏,在排毒中发挥重要作用的外源性药物。已经确定,循环血液中的药物通过基膜上的转运蛋白进入肝脏,然后通过胆小管膜上的转运蛋白排泄到胆汁中。关于摄取的转运体,Na^+依赖性胆汁酸转运体(Ntcp)和有机阴离子转运体1 (oatp1)已被确定。然而,还没有对这些转运蛋白对肝脏药物摄取的贡献进行定量研究。在本研究中,我们通过比较将药物带入肝细胞和进入转染dna的哺乳动物细胞的能力,确定了每种转运蛋白在肝脏药物摄取中的作用。结果表明,依赖Na^+的输运系统和独立输运系统都存在多重性。研究正在确定同源转运蛋白(如oatp2和oat3)的作用。关于胆小管膜的转运,利用大鼠和人分离的胆小管膜囊,鉴定了有机阴离子的转运特性。此外,我们还利用从转染dna的细胞中分离的膜泡表征了管状多特异性有机阴离子转运蛋白(cMOAT)的转运特性。此外,作为cMOAT的同源物,我们已经克隆了大鼠和人MRP3(多药耐药相关蛋白3)。对转染了MRP3 cDNA的哺乳动物细胞分离膜囊泡的研究表明,MRP3接受葡萄糖醛酸盐,而不是谷胱甘肽偶联物作为良好的底物。因此,MRP1/2和MRP1/2之间的输运特性存在差异。在培养的大鼠和HepG2细胞中,MRP3被苯巴比妥诱导,这表明MRP3表达水平的差异可能导致人类将外源性药物和/或其偶联物排泄到胆汁中的能力的个体间差异。少
英文摘要
Liver, along with kidney, plays an important role in the detoxification of xenobiotics. It is well established that drugs in the circulating blood are taken up into the liver via transporters on the basal membrane, and then excreted into the bile via transporters on the bile canalicular membrane. Concerning the transporters responsible for the uptake, Na^+-dependent bile acid transporter (Ntcp) and organic anion transporter 1 (oatp1) have been identified. However, no quantitative studies have been performed on the contribution of these transporters to the hepatic uptake of drugs. In the present study, we determined the contribution of each transporter in hepatic drug uptake, by comparing the ability to take up drugs into hepatocytes and into cDNA-transfected mammalian cells. The results suggested the presence of multiplicity for both Na^+-dependent and independent transport systems. Studies are under way to determine the contribution of homologous transporters (such as oatp2 and oat 3) … More . Concerning the transport across the bile canalicular membrane, the transport properties of organic anions has been identified by using the isolated bile canalicular membrane vesicles isolated from rats and humans. In addition, we have characterized the transport properties of canalicular multispecific organic anion transporter (cMOAT) using the membrane vesicles isolated from cDNA-transfected cells. Moreover, as a homologue of cMOAT, we have cloned rat and human MRP3 (multidrug resistance associated protein 3). Studies with isolated membrane vesicles from mammalian cells transfected with MRP3 cDNA, it was demonstrated that MRP3 accepts glucuronides, but not glutathione-conjugates, as good substrates. Thus, the difference in the transport characteristics was demonstrated between MRP1/2 and 3. In rats and HepG2 cells in culture, MRP3 was induced by phenobarbital, suggesting that the difference in the expression level of MRP3 may result in the interindividual difference in the ability to excrete xenobiotics and/or their conjugates into the bile in humans. Less
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木洋史: "肝臓病学の最前線" (中外医学社)山中、滝川編, (1997)
铃木宏:“肝脏疾病的最前沿”(中外医学社)山中伸弥和泷川,(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴木洋史: "肝臓病学の最前線" (中外医学社)中山、滝川編, (1997)
铃木宏:《肝病前沿》(中外医学社),中山和泷川编辑,(1997 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 37 条
    Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
    • 批准号:
      20249008
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.7万
    • 财政年份:
      2008
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
    • 批准号:
      17209005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.78万
    • 财政年份:
      2005
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
    • 批准号:
      15390035
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      2003
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
    • 批准号:
      13557219
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2001
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    国内基金
    海外基金
    CD200-CD200R轴调控小胶质细胞Mrp8/14释放介导抑郁症发病的作用机
    多药耐药性相关蛋白MRP5的工作机理研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      刘忠民
    • 依托单位:
    基于PXR-P-gp/MRP2信号轴和PBPK模型定量研究伏立康唑对维奈克拉药动/药效的影响
    • 批准号:
      2024A02006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      刘斌
    • 依托单位:
    鹅星状病毒2型调控肾脏CXR/RXR/MRP4信号通路致雏鹅痛风的机制研究
    • 批准号:
      32372964
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      吕英军
    • 依托单位: